Hyperlipoproteinemia Type I
3 clinical trials · Condition
◉ Watch Hyperlipoproteinemia Type I
| Record | Firm | Date |
|---|---|---|
| Orlistat for the Treatment of Type I Hyperlipoproteinemia (NCT02767531) | University of Texas Southwestern Medical Center | 2015-12-01 |
| Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia (NCT02098278) | Catabasis Pharmaceuticals | 2014-03-01 |
Track Hyperlipoproteinemia Type I automatically
Every clearance here is in the API, with alerts when new ones post.